Cellular Retinoic Acid Binding Protein 2 (CRABP2) (Middle Region) Peptid
CRABP2
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle CRABP2 Produkte
- CRABP2 (Cellular Retinoic Acid Binding Protein 2 (CRABP2))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- SLVKWESENK MVCEQKLLKG EGPKTSWTRE LTNDGELILT MTADDVVCTR
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- CRABP2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CRABP2 (Cellular Retinoic Acid Binding Protein 2 (CRABP2))
- Hintergrund
-
This gene encodes a member of the retinoic acid (RA, a form of vitamin A) binding protein family and lipocalin/cytosolic fatty-acid binding protein family. The protein is a cytosol-to-nuclear shuttling protein, which facilitates RA binding to its cognate receptor complex and transfer to the nucleus. It is involved in the retinoid signaling pathway, and is associated with increased circulating low-density lipoprotein cholesterol. Alternatively spliced transcript variants encoding the same protein have been found for this gene.
Alias Symbols: RBP6, CRABP-II
Protein Size: 138 - Gen-ID
- 1382
- NCBI Accession
- NM_001199723, NP_001186652
- UniProt
- P29373
-
Sie sind hier:
